Mertz, H. R. (2003). "Irritable bowel syndrome." N Engl J Med 349(22): 2136-46.
 
Thompson, W. G., G. Longstreth, et al. (2000). Chapter 7. Functional bowel disorders and functional abdominal pain. Rome II. The functional gastrointestinal disorders. D. A. Drossman, E. Corazziari, N. J. Talley, W. G. Thompson and W. E. Whitehead. Lawrence, KS, Allen Press Inc.
 
Müller-Lissner, S. A., S. Bollani, et al. (2001). "Epidemiological aspects of irritable bowel syndrome in Europe and North America." Digestion 64(3): 200-4.
 
Torii, A. and G. Toda (2004). "Management of irritable bowel syndrome." Intern Med 43(5): 353-9.
 
Drossman, D. A., M. Camilleri, et al. (2002). "AGA technical review on irritable bowel syndrome." Gastroenterology 123(6): 2108-31.
 
Hungin, A. P., P. J. Whorwell, et al. (2003). "The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects." Aliment Pharmacol Ther 17(5): 643-50.
 
Mach, T. (2004). "The brain-gut axis in irritable bowel syndrome--clinical aspects." Med Sci Monit 10(6): RA125-31.
 
Locke, G. R. (2003). "Natural history of irritable bowel syndrome and durability of the diagnosis." Rev Gastroenterol Disord 3 Suppl 3: S12-7.
 
Heitkemper, M., M. Jarrett, et al. (2004). "Irritable bowel syndrome in women: a common health problem." Nurs Clin North Am 39(1): 69-81.
 
Hulisz, D. (2004). "The burden of illness of irritable bowel syndrome: current challenges and hope for the future." J Manag Care Pharm 10(4): 299-309.
 
Frank, L., L. Kleinman, et al. (2002). "Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases." Clin Ther 24(4): 675-89; discussion 674.
 
Pace, F., P. Molteni, et al. (2003). "Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life." Scand J Gastroenterol 38(10): 1031-8.
 
Gralnek, I. M., R. D. Hays, et al. (2000). "The impact of irritable bowel syndrome on health-related quality of life." Gastroenterology 119(3): 654-60.
 
Akehurst, R. L., J. E. Brazier, et al. (2002). "Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting." Pharmacoeconomics 20(7): 455-62.
 
Boivin, M. (2001). "Socioeconomic impact of irritable bowel syndrome in Canada." Can J Gastroenterol 15 Suppl B: 8B-11B.
 
Leong, S. A., V. Barghout, et al. (2003). "The economic consequences of irritable bowel syndrome: a US employer perspective." Arch Intern Med 163(8): 929-35.
 
Le Pen, C., P. Ruszniewski, et al. (2004). "The burden cost of French patients suffering from irritable bowel syndrome." Scand J Gastroenterol 39(4): 336-43.
 
Coremans, G. (1999). Epidemiology. The irritable bowel syndrome. R. Stockbrügger and F. Pace. London, Mosby International Ltd: 17-24.
 
Thompson, W. G. (2002). A world-view of IBS. London, WB Saunders.
 
Crowell, M. D. (2004). "Role of serotonin in the pathophysiology of the irritable bowel syndrome." Br J Pharmacol 141(8): 1285-93.
 
Talley, N. J. (2001). "Serotoninergic neuroenteric modulators." Lancet 358(9298): 2061-8.
 
Gershon, M. D. (2003). "Serotonin and its implication for the management of irritable bowel syndrome." Rev Gastroenterol Disord 3 Suppl 2: S25-34.
 
Dapoigny, M., R. W. Stockbrügger, et al. (2003). "Role of alimentation in irritable bowel syndrome." Digestion 67(4): 225-33.
 
Whitehead, W. E., L. J. Cheskin, et al. (1990). "Evidence for exacerbation of irritable bowel syndrome during menses." Gastroenterology 98(6): 1485-9.
 
Olden, K. W. (2003). "Irritable bowel syndrome: An overview of diagnosis and pharmacological treatment." Cleveland Clinical Journal of Medicine 70(Suppl 2): S3-S7
 
Ciclitira, P. J. and H. J. Ellis (2003). Celiac disease. Textbook of gastroenterology. T. Yamada, D. H. Alpers, N. Kaplowitz and e. al. Philadelphia, Lippincott Williams & Wilkins: 1580-1598.
 
Stenson, W. F. and J. Korzenik (2003). Inflammatory bowel disease. Textbook of Gastroenterology. A. D. Yamada T, Kaplowitz N et al. Philadelphia, Lippincott Williams & Wilkins: 1699-1759.
 
Scarlett, Y. (2004). "Medical management of fecal incontinence." Gastroenterology 126(1 Suppl 1): S55-S63.
 
Jailwala, J., T. F. Imperiale, et al. (2000). "Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials." Ann Intern Med 133(2): 136-47.
 
Gattuso, J. M. and M. A. Kamm (1994). "Adverse effects of drugs used in the management of constipation and diarrhoea." Drug Saf 10(1): 47-65.
 
Poynard, T., C. Regimbeau, et al. (2001). "Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome." Aliment Pharmacol Ther 15(3): 355-61.